Royal Bank of Canada’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $825K | Buy |
|
|||||
|
2025
Q1 | $218K | Buy |
|
|||||
|
2024
Q4 | $111K | Buy |
|
|||||
|
2024
Q3 | $63K | Sell |
|
|||||
|
2024
Q2 | $237K | Buy |
|
|||||
|
2024
Q1 | $188K | Sell |
|
|||||
|
2023
Q4 | $268K | Sell |
|
|||||
|
2023
Q3 | $236K | Buy |
|
|||||
|
2023
Q2 | $22K | Sell |
|
|||||
|
2023
Q1 | $277K | Sell |
|
|||||
|
2022
Q4 | $218K | Buy |
|
|||||
|
2022
Q3 | $177K | Sell |
|
|||||
|
2022
Q2 | $334K | Sell |
|
|||||
|
2022
Q1 | $388K | Sell |
|
|||||
|
2021
Q4 | $576K | Buy |
|
|||||
|
2021
Q3 | $620K | Buy |
|
|||||
|
2021
Q2 | $179K | Buy |
|
|||||
|
2021
Q1 | $2K | Sell |
|
|||||
|
2020
Q4 | $55K | Buy |
|
|||||
|
2020
Q3 | $43K | Buy |
|
|||||
|
2020
Q2 | $15K | Buy |
|
|||||
|
2020
Q1 | $3K | Buy |
|
|||||
|
2019
Q4 | $3K | Sell |
|
|||||
|
2019
Q3 | $11K | Buy |
|
|||||
|
2019
Q2 | $14K | Buy |
|
|||||
|
2019
Q1 | $23K | Sell |
|
|||||
|
2018
Q4 | $26K | Sell |
|
|||||
|
2018
Q3 | $104K | Buy |
|
|||||
|
2018
Q2 | $60K | Sell |
|
|||||
|
2018
Q1 | $75K | Buy |
|
|||||
|
2017
Q4 | $55K | Buy |
|
|||||
|
2017
Q3 | $64K | Sell |
|
|||||
|
2017
Q2 | $50K | Sell |
|
|||||
|
2017
Q1 | $46K | Sell |
|
|||||
|
2016
Q4 | $52K | Buy |
|
|||||
|
2016
Q3 | $45K | Sell |
|
|||||
|
2016
Q2 | $46K | Sell |
|
|||||
|
2016
Q1 | $56K | Sell |
|
|||||
|
2015
Q4 | $68K | Sell |
|
|||||
|
2015
Q3 | $428K | Buy |
|
|||||
|
2015
Q2 | $808K | Buy |
|
|||||
|
2015
Q1 | $575K | Buy |
|
|||||
|
2014
Q4 | $442K | Buy |
|
|||||
|
2014
Q3 | $340K | Sell |
|
|||||
|
2014
Q2 | $439K | Buy |
|
|||||
|
2014
Q1 | $430K | Buy |
|
|||||
|
2013
Q4 | $144K | Hold |
|
|||||
|
2013
Q3 | $127K | Sell |
|
|||||
|
2013
Q2 | $88K | Buy |
|